These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9333039

  • 1. Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
    El Dirani-Diab R, Sarih-Cottin L, Delord B, Dumon B, Moreau S, Toulme JJ, Fleury H, Litvak S.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2141-8. PubMed ID: 9333039
    [Abstract] [Full Text] [Related]

  • 2. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
    Andreola ML, Calmels C, Michel J, Toulmé JJ, Litvak S.
    Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
    [Abstract] [Full Text] [Related]

  • 3. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P, Prasad VR.
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
    Hiratou T, Tsukahara S, Miyano-Kurosaki N, Takai K, Yamamoto N, Takaku H.
    FEBS Lett; 1999 Jul 30; 456(1):186-90. PubMed ID: 10452555
    [Abstract] [Full Text] [Related]

  • 5. Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.
    Wei X, Götte M, Wainberg MA.
    Nucleic Acids Res; 2000 Aug 15; 28(16):3065-74. PubMed ID: 10931921
    [Abstract] [Full Text] [Related]

  • 6. Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract.
    Hiratou T, Miyano-Kurosaki N, Tsukahara S, Tamura Y, Takai K, Yamamoto N, Takaku H.
    Int J Mol Med; 2000 Feb 15; 5(2):125-32. PubMed ID: 10639589
    [Abstract] [Full Text] [Related]

  • 7. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
    Somasunderam A, Ferguson MR, Rojo DR, Thiviyanathan V, Li X, O'Brien WA, Gorenstein DG.
    Biochemistry; 2005 Aug 02; 44(30):10388-95. PubMed ID: 16042416
    [Abstract] [Full Text] [Related]

  • 8. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E, El Dirani-Diab R, Boulmé F, Fournier M, Nevinsky G, Tarrago-Litvak L, Litvak S, Andreola ML.
    Eur J Biochem; 1998 Jan 15; 251(1-2):487-95. PubMed ID: 9492322
    [Abstract] [Full Text] [Related]

  • 9. Native oligodeoxynucleotides specifically active against human immunodeficiency virus type 1 in vitro: a G-quartet-driven effect?
    Tondelli L, Colonna FP, Garbesi A, Zanella S, Marongiu ME, Corrias S, Loi AG, La Colla P.
    Antimicrob Agents Chemother; 1996 Sep 15; 40(9):2034-8. PubMed ID: 8878576
    [Abstract] [Full Text] [Related]

  • 10. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
    Hiratou T, Miyano-Kurosaki N, Gushima H, Takaku H.
    Nucleosides Nucleotides Nucleic Acids; 2001 Sep 15; 20(4-7):715-8. PubMed ID: 11563099
    [Abstract] [Full Text] [Related]

  • 11. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
    Bordier B, Perala-Heape M, Degols G, Lebleu B, Litvak S, Sarih-Cottin L, Hélène C.
    Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9383-7. PubMed ID: 7568137
    [Abstract] [Full Text] [Related]

  • 12. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
    Andreola ML, Pileur F, Calmels C, Ventura M, Tarrago-Litvak L, Toulmé JJ, Litvak S.
    Biochemistry; 2001 Aug 28; 40(34):10087-94. PubMed ID: 11513587
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
    Hiratou T, Tsukahara S, Takai K, Koyanagi Y, Yamamoto N, Takaku H.
    Nucleic Acids Symp Ser; 1997 Aug 28; (37):221-2. PubMed ID: 9586079
    [Abstract] [Full Text] [Related]

  • 14. PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms.
    Buckheit RW, Lackman-Smith C, Snow MJ, Halliday SM, White EL, Ross LJ, Agrawal VK, Broom AD.
    Antivir Chem Chemother; 1999 Jan 28; 10(1):23-32. PubMed ID: 10079876
    [Abstract] [Full Text] [Related]

  • 15. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
    Boulme F, Perälä-Heape M, Sarih-Cottin L, Litvak S.
    Biochim Biophys Acta; 1997 Apr 10; 1351(3):249-55. PubMed ID: 9130587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL, Smith SJ, Zhao XZ, Das K, Gruber K, Arnold E, Burke TR, Hughes SH.
    J Virol; 2018 Jul 01; 92(13):. PubMed ID: 29643235
    [Abstract] [Full Text] [Related]

  • 18. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
    de Soultrait VR, Lozach PY, Altmeyer R, Tarrago-Litvak L, Litvak S, Andréola ML.
    J Mol Biol; 2002 Nov 22; 324(2):195-203. PubMed ID: 12441099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.